PETALING JAYA: Only two serious reports of adverse events following immunisation (AEFI) involving children between the ages of five and 11 have been recorded as at Feb 25.
National Pharmaceutical Regulatory Agency (NPRA) director Dr Roshayati Mohamad Sani said the cases involved a girl who already had asthma and a boy with Bell’s Palsy or facial paralysis, both 10.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
